{"filing":{"accession_number":"0001104659-26-108004","cik":"0001769484","ticker":"BIOX","company_name":"Bioceres Crop Solutions Corp.","form":"6-K","filing_date":"2026-09-15","report_date":"2026-09-15","primary_document":"tm2625463d1_6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1769484/000110465926108004/tm2625463d1_6k.htm"},"events":[{"id":33725,"run_id":31025,"accession_number":"0001104659-26-108004","anchor_item_number":"EX-99.1","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"This exhibit is a press release announcing Bioceres' fiscal fourth quarter and full-year 2026 financial results, with total revenues of $55.9 million in 4Q26 and $238.3 million in FY26. The document presents comprehensive financial metrics, segment performance, and management commentary on results, which is the hallmark of an earnings release. Material to investors as it discloses significant operational challenges including an 18% revenue decline, ongoing litigation affecting the Pro Farm Group business (classified as discontinued operations), and net losses, though the company achieved positive Adjusted EBITDA in the quarter.","company_name":"Bioceres Crop Solutions Corp.","ticker":"BIOX","filing_date":"2026-09-15","form":"6-K","submitted_at":null,"items":[{"id":37244,"accession_number":"0001104659-26-108004","item_number":"EX-99.1","item_title":"tm2625463d1_ex99-1.htm","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This exhibit is a press release announcing Bioceres' fiscal fourth quarter and full-year 2026 financial results, with total revenues of $55.9 million in 4Q26 and $238.3 million in FY26. The document presents comprehensive financial metrics, segment performance, and management commentary on results, which is the hallmark of an earnings release. Material to investors as it discloses significant operational challenges including an 18% revenue decline, ongoing litigation affecting the Pro Farm Group business (classified as discontinued operations), and net losses, though the company achieved positive Adjusted EBITDA in the quarter.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-16T10:02:18.229770+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":37244,"accession_number":"0001104659-26-108004","item_number":"EX-99.1","item_title":"tm2625463d1_ex99-1.htm","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This exhibit is a press release announcing Bioceres' fiscal fourth quarter and full-year 2026 financial results, with total revenues of $55.9 million in 4Q26 and $238.3 million in FY26. The document presents comprehensive financial metrics, segment performance, and management commentary on results, which is the hallmark of an earnings release. Material to investors as it discloses significant operational challenges including an 18% revenue decline, ongoing litigation affecting the Pro Farm Group business (classified as discontinued operations), and net losses, though the company achieved positive Adjusted EBITDA in the quarter.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-16T10:02:18.229770+00:00","company_name":"Bioceres Crop Solutions Corp.","ticker":"BIOX","filing_date":"2026-09-15"}]}